Skip to main content

Published locations for Ruxolitinib cream meets primary endpoints in phase 3 vitiligo trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ruxolitinib cream meets primary endpoints in phase 3 vitiligo trial

User login

  • Reset your password
  • /content/ruxolitinib-cream-meets-primary-endpoints-phase-3-vitiligo-trial
  • /edermatologynews/article/247032/pigmentation-disorders/ruxolitinib-cream-meets-primary-endpoints
  • /familypracticenews/article/247032/pigmentation-disorders/ruxolitinib-cream-meets-primary-endpoints
  • /internalmedicinenews/article/247032/pigmentation-disorders/ruxolitinib-cream-meets-primary-endpoints
  • /pediatricnews/article/247032/pigmentation-disorders/ruxolitinib-cream-meets-primary-endpoints-phase
  • /pediatrics/article/247032/pigmentation-disorders/ruxolitinib-cream-meets-primary-endpoints-phase-3
  • /internalmedicine/article/247032/pigmentation-disorders/ruxolitinib-cream-meets-primary-endpoints
  • /dermatology/article/247032/pigmentation-disorders/ruxolitinib-cream-meets-primary-endpoints-phase-3
  • /familymedicine/article/247032/pigmentation-disorders/ruxolitinib-cream-meets-primary-endpoints-phase